The hepatic macrophage pool in NASH.
作者信息
Wang Tixiao, Ma Chunhong
机构信息
Key Laboratory for Experimental Teratology of Ministry of Education, Key Laboratory of Infection and Immunity of Shandong Province, and Department of Immunology, School of Basic Medical Sciences, Cheeloo Medical College of Shandong University, Jinan, Shandong, China.
Advanced Medical Research Institute, Shandong University, Jinan, Shandong, China.
出版信息
Cell Mol Immunol. 2021 Aug;18(8):2059-2060. doi: 10.1038/s41423-021-00690-z. Epub 2021 May 11.
Abstract
摘要
相似文献
1
The hepatic macrophage pool in NASH.非酒精性脂肪性肝炎中的肝巨噬细胞池
Cell Mol Immunol. 2021 Aug;18(8):2059-2060. doi: 10.1038/s41423-021-00690-z. Epub 2021 May 11.
2
Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool.非酒精性脂肪性肝炎会引起肝巨噬细胞池内的短暂变化。
Cell Immunol. 2017 Dec;322:74-83. doi: 10.1016/j.cellimm.2017.10.006. Epub 2017 Oct 16.
3
Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.髓系特异性 IRE1α 缺失可减少糖尿病非酒精性脂肪性肝炎诱导的肝癌小鼠模型中的肿瘤发生。
Metabolism. 2020 Jun;107:154220. doi: 10.1016/j.metabol.2020.154220. Epub 2020 Mar 31.
4
Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low-grade inflammation via blockade of Kupffer cell M1 polarization.胃饥饿素通过阻断库普弗细胞 M1 极化改善慢性低度炎症诱导的非酒精性脂肪性肝炎。
J Cell Physiol. 2021 Jul;236(7):5121-5133. doi: 10.1002/jcp.30218. Epub 2020 Dec 21.
5
Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.硫氧还蛋白相互作用蛋白对小鼠库普弗细胞中NLRP3炎性小体的抑制作用作为非酒精性脂肪性肝病发展的一种调节机制。
Oncotarget. 2017 Jun 6;8(23):37657-37672. doi: 10.18632/oncotarget.17489.
6
Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis.枯否细胞自我更新受损改变了非酒精性脂肪性肝炎中肝脏对脂质过载的反应。
Immunity. 2020 Sep 15;53(3):627-640.e5. doi: 10.1016/j.immuni.2020.06.003. Epub 2020 Jun 19.
7
CD44 is a key player in non-alcoholic steatohepatitis.CD44 是非酒精性脂肪性肝炎的关键参与者。
J Hepatol. 2017 Aug;67(2):328-338. doi: 10.1016/j.jhep.2017.03.003. Epub 2017 Mar 16.
8
Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.一种抗氧化类胡萝卜素β-隐黄质对小鼠脂毒性诱导的肝脏胰岛素抵抗和脂肪性肝炎的预防及逆转作用
Endocrinology. 2015 Mar;156(3):987-99. doi: 10.1210/en.2014-1776. Epub 2015 Jan 6.
9
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.库普弗细胞通过产生肿瘤坏死因子-α触发饮食诱导的小鼠模型中非酒精性脂肪性肝炎的发生。
J Biol Chem. 2012 Nov 23;287(48):40161-72. doi: 10.1074/jbc.M112.417014. Epub 2012 Oct 12.
10
Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver.骨桥蛋白表达鉴定了肝脂肪变性中招募的巨噬细胞亚群，与枯否细胞不同。
Immunity. 2020 Sep 15;53(3):641-657.e14. doi: 10.1016/j.immuni.2020.08.004. Epub 2020 Sep 3.
引用本文的文献
1
Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9.咖啡因通过挽救肝脏中的双特异性磷酸酶9来改善代谢相关脂肪性肝炎。
Redox Biol. 2025 Mar;80:103499. doi: 10.1016/j.redox.2025.103499. Epub 2025 Jan 22.
2
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids.利用人多能干细胞衍生的肝类器官构建代谢相关脂肪性肝炎模型。
Hepatol Commun. 2024 Nov 29;8(12). doi: 10.1097/HC9.0000000000000585. eCollection 2024 Dec 1.
3
Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.免疫系统在代谢功能障碍相关脂肪性肝病中的积极作用。
Gastroenterol Rep (Oxf). 2024 Oct 15;12:goae089. doi: 10.1093/gastro/goae089. eCollection 2024.
4
The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH.C5aR1 介导的肝巨噬细胞噬作用在 NASH 中的作用。
Sci Rep. 2024 Jul 26;14(1):17232. doi: 10.1038/s41598-024-68207-y.
5
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.肠道微生物群和免疫细胞在代谢相关脂肪性肝病中的作用：临床影响。
Hepatol Int. 2024 Oct;18(Suppl 2):861-872. doi: 10.1007/s12072-024-10674-6. Epub 2024 Jul 12.
6
Macrophage metabolism in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的巨噬细胞代谢。
Front Immunol. 2023 Oct 4;14:1257596. doi: 10.3389/fimmu.2023.1257596. eCollection 2023.
7
Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD.非酒精性脂肪性肝病病理生理学中不健康营养与昼夜节律失调的进展
Front Clin Diabetes Healthc. 2021 Oct 12;2:691828. doi: 10.3389/fcdhc.2021.691828. eCollection 2021.
8
Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH.特征性基因表达在肝脏单核细胞-巨噬细胞-DC 系统中与 NASH 纤维化的进展相关。
Front Immunol. 2023 Feb 24;14:1098056. doi: 10.3389/fimmu.2023.1098056. eCollection 2023.
9
Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中c-Jun氨基末端激酶激活的机制及治疗靶点
Biomedicines. 2022 Aug 20;10(8):2035. doi: 10.3390/biomedicines10082035.
10
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis.非酒精性脂肪性肝炎和肝纤维化的精准液体活检。
Gut. 2023 Feb;72(2):392-403. doi: 10.1136/gutjnl-2022-327498. Epub 2022 Jul 12.
Zotero 插件